Replies to post #207038 on Biotech Values

[DewDiligence]

SNY/Lonza ink 50/50 JV for high-capacity biologics facility to be built in Switzerland:

http://mediaroom.sanofi.com/sanofi-and-lonza-enter-into-a-strategic-partnership-to-establish-a-large-scale-biologics-production-facility/

The initial investment is about $290M. The plant is expected to be operational in 2020.